US › Healthcare

Azitra Inc (AZTR)

US · Healthcare · Biotechnology

$0.14+4.08%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

Net profit

$-3.9M

Profit YoY

-28.0%

EPS

$-0.25

EPS estimate

$-0.04

EPS came in at -0.25 against a street estimate of -0.04 — a miss of 525.0%.

Key statistics

Market cap

$2.1M

Forward P/E

0.0

P/B

0.20

Book value

$0.65

EPS (TTM)

$-0.95

52-week high

$1.36

52-week low

$0.10

50-day MA

$0.18

200-day MA

$0.27

Beta

-1.18

Analyst view

Analysts rate Azitra Inc a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $0.78.

Shareholding

Insiders

28.42%

Institutions

6.27%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Azitra Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.